UnitedHealth unit to add eight insulin products to its reimb

The unit, Optum Rx, will move eight products, including all short- and rapid-acting insulin, to tier one, or preferred status, which offers the lowest price for consumers and is effective Jan. 1. Eli Lilly, Novo Nordisk and Sanofi will have their insulin products added to the preferred status.

Related Keywords

United States , Bengaluru , Karnataka , India , Americans , Sriparna Roy , Shounak Dasgupta , Eli Lilly , Reuters , Novo Nordisk , Anild Silva , Unitedhealth , Insulin Products , Pharmacy Benefit Manager , Reimbursement , Preferred Status , Rapid Acting Insulin , Insulin ,